EPITERNA develops affordable products that utilize scientific advancements in gerontology to safely slow the aging process in companion dogs and cats. By targeting age-related diseases and functional decline, the company aims to extend the healthy lifespan of pets and enhance the quality of life for their owners.
Funding
$11.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Companion dogs and cats experience age-related diseases and functional decline, impacting their quality of life and lifespan. Current interventions to address these issues can be expensive or ineffective.
Solution
EPITERNA develops accessible products leveraging scientific advancements in gerontology to mitigate the effects of aging in companion animals. By targeting the underlying mechanisms of age-related diseases and functional decline, EPITERNA aims to extend the healthy lifespan of dogs and cats. The company focuses on providing safe and effective solutions that improve the overall well-being of pets as they age, enhancing their quality of life and reducing the burden of age-related ailments. This approach allows pet owners to enjoy more healthy years with their beloved companions.
Target Audience
The primary target audience is owners of companion dogs and cats who are seeking to improve their pets' health and extend their healthy lifespan.
Features
- Targets age-related diseases in dogs and cats.
- Utilizes scientific advancements in gerontology.
- Focuses on safely slowing the aging process.